HCPCS Codes for Other medical items or services


  • C9037

    Injection, risperidone (perseris), 0.5 mg
  • C9038

    Injection, mogamulizumab-kpkc, 1 mg
  • C9039

    Injection, plazomicin, 5 mg
  • C9040

    Injection, fremanezumab-vfrm, 1mg
  • C9041

    Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg
  • C9042

    Injection, bendamustine hcl (belrapzo), 1 mg
  • C9043

    Injection, levoleucovorin, 1 mg
  • C9044

    Injection, cemiplimab-rwlc, 1 mg
  • C9045

    Injection, moxetumomab pasudotox-tdfk, 0.01 mg
  • C9046

    Cocaine hydrochloride nasal solution (goprelto), 1 mg
  • C9047

    Injection, caplacizumab-yhdp, 1 mg
  • C9048

    Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
  • C9049

    Injection, tagraxofusp-erzs, 10 mcg
  • C9050

    Injection, emapalumab-lzsg, 1 mg
  • C9051

    Injection, omadacycline, 1 mg
  • C9052

    Injection, ravulizumab-cwvz, 10 mg
  • C9053

    Injection, crizanlizumab-tmca, 1 mg
  • C9054

    Injection, lefamulin (xenleta), 1 mg
  • C9055

    Injection, brexanolone, 1mg
  • C9056

    Injection, givosiran, 0.5 mg
  • C9057

    Injection, cetirizine hydrochloride, 1 mg
  • C9058

    Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg
  • C9059

    Injection, meloxicam, 1 mg
  • C9060

    Fluoroestradiol f18, diagnostic, 1 mci
  • C9061

    Injection, teprotumumab-trbw, 10 mg
  • C9062

    Injection, daratumumab 10 mg and hyaluronidase-fihj
  • C9063

    Injection, eptinezumab-jjmr, 1 mg
  • C9064

    Mitomycin pyelocalyceal instillation, 1 mg
  • C9065

    Injection, romidepsin, non-lyophilized (e.g. liquid), 1mg
  • C9066

    Injection, sacituzumab govitecan-hziy, 2.5 mg
  • C9067

    Gallium ga-68, dotatoc, diagnostic, 0.01 mci
  • C9069

    Injection, belantamab mafodontin-blmf, 0.5 mg
  • C9070

    Injection, tafasitamab-cxix, 2 mg
  • C9071

    Injection, viltolarsen, 10 mg
  • C9072

    Injection, immune globulin (asceniv), 500 mg
  • C9073

    Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
  • C9074

    Injection, lumasiran, 0.5 mg
  • C9075

    Injection, casimersen, 10 mg
  • C9076

    Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
  • C9077

    Injection, cabotegravir and rilpivirine, 2mg/3mg
  • C9078

    Injection, trilaciclib, 1 mg
  • C9079

    Injection, evinacumab-dgnb, 5 mg
  • C9080

    Injection, melphalan flufenamide hydrochloride, 1 mg
  • C9081

    Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
  • C9082

    Injection, dostarlimab-gxly, 100 mg
  • C9083

    Injection, amivantamab-vmjw, 10 mg
  • C9084

    Injection, loncastuximab tesirine-lpyl, 0.1 mg
  • C9085

    Injection, avalglucosidase alfa-ngpt, 4 mg
  • C9086

    Injection, anifrolumab-fnia, 1 mg
  • C9087

    Injection, cyclophosphamide, (auromedics), 10 mg